Keyword: Vaccines

News

AstraZeneca Sells US Site to National Resilience

07.12.2022 -

Two weeks after annnouncing that it would no longer seek to market its Covid-19 vaccine in the US, Anglo-Swedish drugmaker AstraZeneca has unveiled plans to sell its...

News

AstraZeneca Withdraws US Vaxzevria Launch Plan

16.11.2022 -

AstraZeneca (AZ) has announced it is permanently backing away from any plans to sell its Vaxzevria-branded Covid-19 vaccine in the US.

News

BioNTech Buys Novartis Singapore Plant for Asia HQ

15.11.2022 -

German Covid-19 vaccine specialist BioNTech has acquired a production facility in Singapore from Swiss drugmaker Novartis that will serve as a manufacturing base in...

News

Pfizer/BioNTech Bivalent Covid Booster Wins Approvals

10.11.2022 -

UK health regulator Medicines and Healthcare products Regulatory Agency (MHRA) has approved the Pfizer/BioNTech bivalent Covid-19 vaccine for use as a booster in people...

News

Omicron-targeted Covid Boosters may not be Better

28.10.2022 -

The newly launched bivalent mRNA-based Covid-19 booster shots from Moderna and Pfizer/BioNTech did not show a major improvement over the companies’ first-generation...

News

EU Public Prosecutor Probes Vaccine Mega Order

20.10.2022 -

The European Public Prosecutors Office (EPPO) has confirmed that it is looking into the EU Commission’s ordering of Covid-19 vaccines, with the probe thought to pertain...

News

Germany’s Merck Expands French Facility

12.09.2022 -

German science and technology company Merck has announced plans to invest more than €130 million at its site in Molsheim, France, to expand capacities for single-use...

News

EMA’s CHMP Greenlights Omicron-1 Vaccines

06.09.2022 -

The human medicines committee (CHMP) of EU drug regulator European Medicines Agency (EMA) has recommended approval of the updated Covid-19 vaccines of Pfizer-BioNTech and...